Ballard TM - Search Results

1

PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.

Saenger S, Goeldner C, Frey JR, Ozmen L, Ostrowitzki S, Spooren W, Ballard TM, Prinssen E, Borroni E, Metzger F. Saenger S, et al. Among authors: ballard tm. Growth Horm IGF Res. 2011 Oct;21(5):292-303. doi: 10.1016/j.ghir.2011.07.006. Epub 2011 Aug 23. Growth Horm IGF Res. 2011. PMID: 21865068

2

Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.

Freichel C, Neumann M, Ballard T, Müller V, Woolley M, Ozmen L, Borroni E, Kretzschmar HA, Haass C, Spooren W, Kahle PJ. Freichel C, et al. Neurobiol Aging. 2007 Sep;28(9):1421-35. doi: 10.1016/j.neurobiolaging.2006.06.013. Epub 2006 Jul 26. Neurobiol Aging. 2007. PMID: 16872721

3

Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.

Spooren W, Ballard T, Gasparini F, Amalric M, Mutel V, Schreiber R. Spooren W, et al. Behav Pharmacol. 2003 Jul;14(4):257-77. doi: 10.1097/01.fbp.0000081783.35927.8f. Behav Pharmacol. 2003. PMID: 12838033 Review.

4

The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.

Ballard TM, Woolley ML, Prinssen E, Huwyler J, Porter R, Spooren W. Ballard TM, et al. Psychopharmacology (Berl). 2005 Apr;179(1):218-29. doi: 10.1007/s00213-005-2211-9. Epub 2005 Mar 1. Psychopharmacology (Berl). 2005. PMID: 15739074

5

Pharmacological characterization of senktide-induced tail whips.

Nordquist RE, Ballard TM, Algeyer B, Pauly-Evers M, Ozmen L, Spooren W. Nordquist RE, et al. Among authors: ballard tm. Neuropharmacology. 2010 Jan;58(1):259-67. doi: 10.1016/j.neuropharm.2009.04.018. Epub 2009 Jun 21. Neuropharmacology. 2010. PMID: 19540857

6

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

Michalon A, Sidorov M, Ballard TM, Ozmen L, Spooren W, Wettstein JG, Jaeschke G, Bear MF, Lindemann L. Michalon A, et al. Among authors: ballard tm. Neuron. 2012 Apr 12;74(1):49-56. doi: 10.1016/j.neuron.2012.03.009. Neuron. 2012. PMID: 22500629 Free PMC article.

7

Cognitive performance in neurokinin 3 receptor knockout mice.

Nordquist RE, Delenclos M, Ballard TM, Savignac H, Pauly-Evers M, Ozmen L, Spooren W. Nordquist RE, et al. Among authors: ballard tm. Psychopharmacology (Berl). 2008 Jun;198(2):211-20. doi: 10.1007/s00213-008-1119-6. Epub 2008 Mar 20. Psychopharmacology (Berl). 2008. PMID: 18351324

8

Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.

Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, von Kienlin M, Ozmen L. Grueninger F, et al. Among authors: ballard tm. Neurobiol Dis. 2010 Feb;37(2):294-306. doi: 10.1016/j.nbd.2009.09.004. Epub 2009 Sep 23. Neurobiol Dis. 2010. PMID: 19781645

9

RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.

Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA, Basile J, Gasser R, Moreau JL, Wettstein JG, Buettelmann B, Knust H, Thomas AW, Trube G, Hernandez MC. Ballard TM, et al. Psychopharmacology (Berl). 2009 Jan;202(1-3):207-23. doi: 10.1007/s00213-008-1357-7. Epub 2008 Oct 21. Psychopharmacology (Berl). 2009. PMID: 18936916

10

Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.

Goeldner C, Ballard TM, Knoflach F, Wichmann J, Gatti S, Umbricht D. Goeldner C, et al. Among authors: ballard tm. Neuropharmacology. 2013 Jan;64:337-46. doi: 10.1016/j.neuropharm.2012.08.001. Epub 2012 Aug 23. Neuropharmacology. 2013. PMID: 22992331 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page